Page 3,786«..1020..3,7853,7863,7873,788..3,8003,810..»

Experts call for increased awareness of links between brain injuries and crime

Posted: Published on August 12th, 2014

EXPERTS have called for increased awareness in the criminal justice system of how brain injuries are linked to offending. The British Psychological Society says the "hidden" nature of brain injuries and neurodisabilities means many offenders experience discriminating treatment when entering the system. MSPs on Holyrood's Justice Committee took evidence from a panel of doctors and academics on the issue. Research has shown that the level of brain injuries among offenders in custody is much higher than in the general population. Professor Tom McMillan, professor of clinical neuropsychology, at the University of Glasgow, told MSPs that a study of three prisons in the Glasgow area showed 23 per cent of prisoners had suffered a head injury in their lives, with 50 per cent of these classified as severe. A report by Professor Huw Williams, of the Centre for Clinical Neuropsychology Research at the University of Exeter, found that despite the higher prevalence among offenders, it is rare for criminal justice professionals to consider whether an offender may have a brain injury, or for appropriate rehabilitation services to be offered. His report suggests the need for increased awareness of brain injury throughout the criminal justice process and in related areas such as … Continue reading

Posted in Brain Injury Treatment | Comments Off on Experts call for increased awareness of links between brain injuries and crime

Friends fighting MS at Fringe

Posted: Published on August 12th, 2014

Published: 12 Aug 2014 08:001 comment A ROYAL Mile marathon mission will help a Peeblesshire powerwalker raise vital cash. Helen Highley of Macbiehill, and three friends will battle Edinburgh Fringe Festival crowds as they attempt to walk the length of the street 26 times on August 16. The Multiple Sclerosis Society Scotland will benefit from the womens charity challenge during the biggest arts festival in the world. Helen and her friend Penny Thompson both have a personal connection to multiple sclerosis (MS). Their walking pals Michelle Sinclair and Mags Doyle signed up to support the cause too. Helen said: My daughter-in-law Karine was diagnosed with primary progressive MS last year. She tackles everything MS throws at her with a wicked sense of humour, and she has been an absolute inspiration to us. Karine could have fallen in a heap, but shes put her energy into regaining her mobility and getting on with life. Read the original here: Friends fighting MS at Fringe … Continue reading

Posted in MS Treatment | Comments Off on Friends fighting MS at Fringe

B12 Injection Therapy as Part of Hormone Replacement Therapy – Video

Posted: Published on August 12th, 2014

B12 Injection Therapy as Part of Hormone Replacement Therapy Vitamin B12 injection therapy is a very beneficial program to incorporate into any hormone replacement therapy program involving HGH or Sermorelin injections, and Testosterone programs utilizing... By: Hgh Service … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on B12 Injection Therapy as Part of Hormone Replacement Therapy – Video

Cancer linked to menopause drug in new report

Posted: Published on August 12th, 2014

Popular menopause drugs made in part from estrogen found in the urine of pregnant horses have caused breast cancer in thousands of Canadian women, according to allegations in a new report by the Canadian Cancer Societys top epidemiologist. The body of evidence to date overwhelmingly points to a causal connection between the use of Premplus and the development of invasive breast cancer in women, the societys Prithwish De wrote in a report to be filed in a Canadian class-action lawsuit against drug manufacturer Wyeth Canada, now owned by Pfizer. The drug manufacturer states that its products are safe and effective when used as directed and they do not cause breast cancer. A trial date is set for October in a Vancouver court. According to the report, hormone replacement therapy was the main risk factor in an estimated 12,000 new Canadian breast cancer cases detected between 1994 and 2006 at a time when Wyeths products, Premarin and Premplus, dominated the market. The drugs remain on the market, but in more recent years they have contained strong warnings and are also prescribed in lower doses. In the lawsuit against Wyeth, women like Hamiltons Rose Scarff, 70, say they were not properly warned … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Cancer linked to menopause drug in new report

Clues emerge to genetic architecture of cognitive abilities in children

Posted: Published on August 12th, 2014

PUBLIC RELEASE DATE: 11-Aug-2014 Contact: Dana Weidig weidigd@email.chop.edu 267-426-6092 Children's Hospital of Philadelphia How genes affect intelligence is complicated. Multiple genes, many yet unknown, are thought to interact among themselves and with environmental factors to influence the diverse abilities involved in intelligence. A large new genetic study in thousands of children and adolescents offers early glimpses of the overall patterns and connections among cognitive abilities such as language reasoning, reading skill and types of memory. The findings may lead to new tools in understanding human cognitive development and neuropsychiatric disorders. "This research is one of the first to use a molecular genetic approach to evaluate complex cognitive traits in a pediatric sample," said one of the study's two co-senior leaders, Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at The Children's Hospital of Philadelphia. "Uncovering the genetic architecture of these diverse cognitive abilities may offer new insights into cognitive development and may ultimately allow investigators to identify useful biomarkers for diagnosing and predicting risks of neuropsychiatric conditions." The study appeared online July 15 in Molecular Psychiatry. Hakonarson's co-senior author is psychiatrist Raquel Gur, M.D., Ph.D., director of Neuropsychiatry in the Perelman School of Medicine at the University … Continue reading

Comments Off on Clues emerge to genetic architecture of cognitive abilities in children

GW researcher receives grant to develop genetic tools to study parasitic infections

Posted: Published on August 12th, 2014

PUBLIC RELEASE DATE: 11-Aug-2014 Contact: Lisa Anderson lisama2@gwu.edu 202-994-3121 George Washington University WASHINGTON (Aug. 11, 2014) According to a recent World Health Organization report of the leading causes of death worldwide, one-third of all deaths are due to infectious and parasitic diseases. There are currently no vaccines for parasitic nematode (PN), or worm infections in humans, and development of new drugs and vaccines will stall until researchers have a better understanding of PN biology. John Hawdon, Ph.D., associate professor of microbiology, immunology, and tropical medicine at the George Washington University (GW) School of Medicine and Health Sciences, was recently awarded $430,722 from the National Institutes of Health to develop a model system to study PN infection, which will lead to greater understanding of the infective process and the host's immune response to infection. Due to the requirement of an obligate host and lack of good animal models, investigations have been previously limited. However, thanks to an interdisciplinary team, which includes Hawdon, Damien O'Halloran, Ph.D., and Ioannis Eleftherianos, Ph.D., both assistant professors of biology at the GW Columbian College of Arts and Sciences, a viable model will be developed using the insect PN Heterorhabditis bacteriophora. "The techniques we are developing will … Continue reading

Comments Off on GW researcher receives grant to develop genetic tools to study parasitic infections

Newly Discovered Heart Molecule Could Lead to Effective Treatment for Heart Failure

Posted: Published on August 12th, 2014

Contact Information Available for logged-in reporters only Newswise INDIANAPOLIS -- Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure. The newly discovered molecule provides the heart with a tool to block a protein that orchestrates genetic disruptions when the heart is subjected to stress, such as high blood pressure. When the research team, led by Ching-Pin Chang, M.D., Ph.D., associate professor of medicine at the Indiana University School of Medicine, restored levels of the newly discovered molecule in mice experiencing heart failure, the progression to heart failure was stopped. The research was published in the online edition of the journal Nature. The newly discovered molecule is known as a long non-coding RNA. RNA's usual role is to carry instructions -- the code -- from the DNA in a cell's nucleus to the machinery in the cell that produces proteins necessary for cell activities. In recent years, scientists have discovered several types of RNA that are not involved in protein coding but act on their own. The role in the heart of long non-coding RNA has been unknown. But the researchers determined that the newly discovered non-coding RNA, which they named … Continue reading

Comments Off on Newly Discovered Heart Molecule Could Lead to Effective Treatment for Heart Failure

Penn’s Basser Research Center for BRCA Names BRCA1 Founder Mary-Claire King Winner of the 2014 Basser Global Prize

Posted: Published on August 12th, 2014

Contact Information Available for logged-in reporters only Newswise PHILADELPHIA Twenty years after the first identification of the BRCA1 gene, the University of Pennsylvanias Basser Research Center for BRCA will honor the geneticist credited with its founding with the second annual Basser Global Prize. The award will go to human genetics researchers and expert Mary-Claire King, PhD, American Cancer Society Research Professor of Genetics and Medicine at the University of Washington. King has been a pioneer in the development of experimental and bioinformatics genomics tools to study common, complex human diseases and health conditions. The Basser Global Prize provides $200,000 in unrestricted support of the winner's innovative BRCA1/2 related research efforts. As part of the award, King will give the keynote address at the annual Basser Research Center for BRCA Symposium scheduled for May 11-12, 2015, at which time she will receive the Basser Trophy and a personal $10,000 cash prize. Were very excited to honor Dr. Kings accomplishments in BRCA-related research, particularly as this year marks twenty years since the initial cloning of the BRCA1 gene, said Susan Domchek, MD, executive director of the Basser Research Center and the Basser Professor of Medicine in Penns Abramson Cancer Center. The identification … Continue reading

Posted in Human Genetics | Comments Off on Penn’s Basser Research Center for BRCA Names BRCA1 Founder Mary-Claire King Winner of the 2014 Basser Global Prize

23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn’s Disease

Posted: Published on August 12th, 2014

Released: 12-Aug-2014 9:00 AM EDT Source Newsroom: 23andMe Contact Information Available for logged-in reporters only Newswise Mountain View, Calif. August 12, 2014 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4 million people in the U.S. alone suffer from IBD, according to estimates from the Centers for Disease Control and Prevention (CDC). While IBD is known to be more common in developed countries, the exact cause of this chronic illness is still unknown and there is no cure. The collaboration represents an innovative effort for both companies designed to explore the underlying genetics of IBD and it is hoped that the effort will ultimately lead to potential new or improved treatments for IBD. We are excited to team up with Pfizer to take an innovative, consumer-centered approach to try to understand the fundamentals of inflammatory bowel disease and the variability of treatment response, said 23andMe CEO and Co-Founder Anne Wojcicki. Pfizer is committed to bringing forward new … Continue reading

Posted in Human Genetics | Comments Off on 23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn’s Disease

Minecraft: Block Party #19 – ADVANCED GENETICS (Yogscast Complete Mod Pack) – Video

Posted: Published on August 12th, 2014

Minecraft: Block Party #19 - ADVANCED GENETICS (Yogscast Complete Mod Pack) Join brent on the Block Party as he starts working with ADVANCED GENETICS a mod where you can mutate and gain powers. What will be his first goal?! FOLLOW Brent http://twitter.com/brentcopela... By: YOGSCAST Brent Eric … Continue reading

Posted in Genetics | Comments Off on Minecraft: Block Party #19 – ADVANCED GENETICS (Yogscast Complete Mod Pack) – Video

Page 3,786«..1020..3,7853,7863,7873,788..3,8003,810..»